The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug of...
In just a few months, the coronavirus has gone from being completely unknown to being the focus of countless scientific investigations around the world....
Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Hospital...
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better understanding...
Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating hematological...
Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.
A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS of Barcelona...
Hospital Clínic of Barcelona will apply the leading comprehensive liquid biopsy test currently available for patients with advanced cancer, in the context...
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining the...
